We sit down with you and build your perfect lead list. Book a call with founders.

CellChorus Analysis: $3M Raised

What is CellChorus?

CellChorus develops TIMING™ technology to analyze immune cell behavior, enhancing understanding of cell interactions and performance for clinical applications.

Founded
2020
Revenue
$1.4M
Company Stage
Seed
YC Batch
S21

Product Features & Capabilities

  • TIMING™ platform, single-cell technology, evaluates cell movement, activation, interaction, killing, survival, time-lapse imaging microscopy, neural network detection, characterizes migration, contact dynamics, cell death, high-throughput microscopy experiments, artificial intelligence application,

How much CellChorus raised

Grant - $2,500,000

May 2, 2024
Lead Investor: NCATS

Who are the founders of CellChorus

Investors

  • National Institutes of Health (NIH)
  • National Center for Advancing Translational Sciences (NCATS)
  • Y Combinator
  • NVIDIA Inception
  • National Institute of General Medical Sciences
  • Asymmetry Ventures
  • Texas Halo Fund

Find more companies like CellChorus

in Y Combinator batch S21 companies

Financial Overview

$1.4MEstimated Revenue
$3MTotal Raised
Grant$2,500,000
May 2, 2024
Investors: NCATS
Want to research more data points on CellChorus?
Start with Extruct